Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

SF 3859

as introduced - 91st Legislature (2019 - 2020) Posted on 03/03/2020 09:29am

KEY: stricken = removed, old language.
underscored = added, new language.

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4
1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19

A bill for an act
relating to human services; requiring the commissioner of human services to
develop a process to identify and report 340B drugs at point of sale.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1. new text begin ENCOUNTER REPORTING OF 340B DRUGS.
new text end

new text begin (a) By January 1, 2021, the commissioner of human services, in consultation with
representatives of federally qualified health centers, as defined in Minnesota Statutes, section
145.9269, subdivision 1, shall develop a process to identify and report at point of sale the
340B drugs that are dispensed to enrollees of managed care organizations served by federally
qualified health centers in order to exclude 340B claims from the Medicaid drug rebate
program. In developing this process, the commissioner shall work with federally qualified
health centers, managed care organizations, and contracted pharmacies to ensure that 340B
entities are allowed to maximize the 340B program and the 340B program drug discounts
when 340B entities utilize contract pharmacies for patients enrolled in the prepaid medical
assistance program, while ensuring that duplicate discounts for these drugs do not occur.
new text end

new text begin (b) The commissioner shall inform the chairs and ranking minority members of the
legislative committees with jurisdiction over health and human services policy and finance
of the process developed under paragraph (a), or if applicable, the reasons why this process
could not be developed as required.
new text end